Integra LifeSciences Holdings Corporation (IART) CEO Peter Arduini on Q3 2020 Results - Earnings Call Transcript

SA Transcripts
153.96K Followers

Q3: 2020-10-28 Earnings Summary

EPS of $0.80 beats by $0.26
 | Revenue of $370.23M (-2.34% Y/Y) beats by $10.91M

Integra LifeSciences Holdings Corporation (NASDAQ:IART) Q3 2020 Earnings Conference Call October 28, 2020 8:30 AM ET

Company Participants

Mike Beaulieu - Director, Investor Relations
Carrie Anderson - Chief Financial Officer
Glenn Coleman - Chief Operating Officer
Peter Arduini - President & Chief Executive Officer

Conference Call Participants

Raj Denhoy - Jefferies
Dave Turkaly - JMP Securities
Ryan Zimmerman - BTIG
Kaila Krum - Truist Securities
Shagun Singh - Wells Fargo
Steven Lichtman - Oppenheimer
Robbie Marcus - JPMorgan
Matt Miksic - Credit Suisse
Travis Steed - Bank of America
Jason Bedford - Raymond James
Matt Taylor - UBS
Ryan Zimmerman - BTIG

Operator

Good day and welcome to the Integra LifeSciences Third Quarter 2020 Financial Results Call. Today's conference is being recorded.

At this time, I would like to turn the conference over to Mike Beaulieu, please go ahead, sir.

Mike Beaulieu

Thank you, Samantha. Good morning and thank you for joining the Integra LifeSciences third quarter 2020 earnings conference call. Joining me on the call are; Peter Arduini, President and Chief Executive Officer; Glenn Coleman, Chief Operating Officer; and Carrie Anderson, Chief Financial Officer.

Earlier today we issued a press release announcing our third quarter 2020 financial results. The release and corresponding earnings presentation, which we will reference during the call, are available at integralife.com under Investors, Events & Presentations, and the file named Third Quarter 2020 Earnings Call Presentation.

Before we begin, I’d like to remind you that many of the statements made during this call may be considered forward-looking statements. Factors that could cause actual results to differ materially are discussed in the company’s Exchange Act reports filed with the SEC and in the release.

Also, in light of the ongoing COVID-19 uncertainty, we are disclosing more information today for investors about recent, current, and anticipated future business performance than we

Recommended For You

About IART Stock

SymbolLast Price% Chg
Market Cap
PE
Yield
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on IART